Equaline Maximum Strength Lidocaine Patches

Case Name (Date)

Sheiner et al. v. Supervlau Inc.
22-cv-10262, S.D.N.Y.
(Dec. 2022)

Product/Service

Equaline Maximum Strength Lidocaine Patches

Allegations

Misleadingly marketing that products provide “Up to 8 Hours of Relief” when they do not adhere for eight hours

Misleadingly marketing products as “Maximum Strength” when they do not stay on for eight hours and, as a result, they do not deliver the “Maximum Strength” amount of lidocaine

Misleadingly marketing that products “Desensitize Aggravated Nerves” when patches are not capable of providing such relief

Status

Pending